Try our beta test site

REAL3 Trial of Efficacy of EOX With/Without Panitumumab in Previously Untreated Adv OG Cancer (REAL3)

This study has been terminated.
(Lack of efficacy)
Information provided by (Responsible Party):
Professor David Cunningham, Royal Marsden NHS Foundation Trust Identifier:
First received: January 16, 2009
Last updated: December 10, 2012
Last verified: December 2012